BIOMAT Database Logo BIOMAT Database Logo

[Ungual pigmentation in patients with AIDS treated with zidovudine]. 1990

C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz

UI MeSH Term Description Entries
D008297 Male Males
D009260 Nail Diseases Diseases of the nail plate and tissues surrounding it. The concept is limited to primates. Disease, Nail,Diseases, Nail,Nail Disease
D010859 Pigmentation Disorders Diseases affecting PIGMENTATION, including SKIN PIGMENTATION. Incontinentia Pigmenti Achromians,Ito Syndrome,Schamberg's Disease,Schamberg Disease,Disease, Schamberg,Disease, Schamberg's,Disorder, Pigmentation,Disorders, Pigmentation,Pigmentation Disorder,Schambergs Disease,Syndrome, Ito
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
Serum thymidine kinase in AIDS patients treated with zidovudine.
August 1987, Lancet (London, England),
C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
May 1990, The New England journal of medicine,
C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
Lymphocytes' intrinsic lymphoproliferative capacity in patients with AIDS treated with zidovudine.
October 1989, AIDS (London, England),
C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
Pigmented nail bands and mucocutaneous pigmentation in HIV-positive patients treated with zidovudine.
April 1990, Journal of the American Academy of Dermatology,
C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
January 1991, BMJ (Clinical research ed.),
C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
Wernicke's encephalopathy in AIDS patient treated with zidovudine.
April 1987, Lancet (London, England),
C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group.
March 1992, JAMA,
C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
[Bluish pigmentation of the nails in AIDS patients. Possibly an adverse effect of Zidovudine?].
October 1988, Revista clinica espanola,
C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
Nail pigmentation associated with zidovudine.
January 1989, Scandinavian journal of infectious diseases,
C Ramos, and P Arazo, and A García Aranda, and J M Franco, and P Samperiz, and J M Aguirre, and J R Muñoz
Nail pigmentation associated with zidovudine.
November 1989, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!